Beijing Airdoc Technology Co (HKSE:02251) EBITDA Margin % : -73.80% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Beijing Airdoc Technology Co's EBITDA for the six months ended in Jun. 2024 was HK$-74.5 Mil. Beijing Airdoc Technology Co's Revenue for the six months ended in Jun. 2024 was HK$100.9 Mil. Therefore, Beijing Airdoc Technology Co's EBITDA margin for the quarter that ended in Jun. 2024 was -73.80%.

Beijing Airdoc Technology Co EBITDA Margin % Historical Data

The historical data trend for Beijing Airdoc Technology Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co EBITDA Margin % Chart

Beijing Airdoc Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

-274.89

-154.75

-110.03

-140.45

-55.58

Beijing Airdoc Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBITDA Margin %	Get a 7-Day Free Trial					-236.84	-93.17	-32.37	-71.34	-73.80

Competitive Comparison of Beijing Airdoc Technology Co's EBITDA Margin %

For the Health Information Services subindustry, Beijing Airdoc Technology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Airdoc Technology Co's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beijing Airdoc Technology Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Beijing Airdoc Technology Co's EBITDA Margin % falls into.

Beijing Airdoc Technology Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Beijing Airdoc Technology Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-123.993	/	223.092
	=	-55.58 %

Beijing Airdoc Technology Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-74.456	/	100.883
	=	-73.80 %

Beijing Airdoc Technology Co (HKSE:02251) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Beijing Airdoc Technology Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Airdoc Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN, 100089

Website

https://www.airdoc.com

Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses, and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective, and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices, and other services.

Executives

Yadong Beichen Venture Investment Co., Ltd.	2101 Beneficial owner
Shanghai Ruikun Venture Capital Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun Industrial Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Zhang Dalei	2501 Other
Mialkos Tomasz Jakub	2101 Beneficial owner
Lake Bleu Capital (hong Kong) Limited	2102 Investment manager
Chen Mingqiang	2501 Other
Gao Fei	2501 Other
Niagara Falls Holding Limited	2101 Beneficial owner
China Life Franklin Asset Management Co., Limited

Beijing Airdoc Technology Co Headlines

No Headlines